This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: The University of North Carolina at Chapel Hill. Active years: 2019-2022.
Location History:
- Carrboro, NC (US) (2019)
- Newton Center, MA (US) (2022)
Company Filing History:
Years Active: 2019-2022
Title: Douglas Widman: Innovator in Dengue Virus Research
Introduction
Douglas Widman is a notable inventor based in Newton, MA (US). He has made significant contributions to the field of virology, particularly in the study of dengue viruses. With a total of 2 patents, his work focuses on developing methods and compositions that enhance our understanding and treatment of dengue virus infections.
Latest Patents
Widman's latest patents include innovative approaches to dengue virus research. The first patent, titled "Methods and compositions for dengue virus serotype 4 epitopes," provides compositions and methods of use that involve a chimeric dengue virus E glycoprotein. This glycoprotein backbone includes amino acid substitutions that introduce an epitope from a different dengue virus serotype. The second patent, "Methods and compositions for recombinant dengue viruses for vaccine and diagnostic development," similarly offers compositions and methods that utilize a chimeric dengue virus E glycoprotein. This invention also incorporates amino acid substitutions to introduce an epitope recognized by an antibody from a different dengue virus serotype.
Career Highlights
Douglas Widman is affiliated with the University of North Carolina at Chapel Hill, where he continues to advance research in the field of infectious diseases. His work has been instrumental in developing new strategies for vaccine and diagnostic applications related to dengue viruses.
Collaborations
Widman collaborates with esteemed colleagues such as Boyd Yount and Aravinda Desilva. Their combined expertise contributes to the innovative research being conducted at the University of North Carolina at Chapel Hill.
Conclusion
Douglas Widman's contributions to dengue virus research through his patents and collaborations highlight his role as a key innovator in the field. His work not only enhances our understanding of the virus but also paves the way for future advancements in vaccine and diagnostic development.